Shakedown Lawsuits, Not Safety, Explain Drug Shortages
On October 31, 2023, U.S. Sen. Richard Blumenthal (D-CT) sent a letter to U.S. Food and Drug Administration (FDA) Commissioner Robert Califf, M.D. urging him to take “appropriate actions to investigate and recall products with unacceptable levels of …